Using a CRISPR/Cas9-mediated approach, this tumor-suppressing activity of the LKB1-SIK1 axis was also demonstrated in a mouse model of oncogenic KRAS-driven lung adenocarcinoma (163). Here, SIK1 is linked to neoplasm.